Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis
Dennis G. Moledina, … , Lloyd G. Cantley, Chirag R. Parikh
Dennis G. Moledina, … , Lloyd G. Cantley, Chirag R. Parikh
Published May 16, 2019
Citation Information: JCI Insight. 2019;4(10):e127456. https://doi.org/10.1172/jci.insight.127456.
View: Text | PDF
Clinical Research and Public Health Inflammation Nephrology

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis

  • Text
  • PDF
Abstract

BACKGROUND Clinical diagnosis of acute interstitial nephritis (AIN) is challenging because of lack of a diagnostic biomarker and requires a kidney biopsy. We hypothesized that AIN is mediated by specific T cell subsets such that specific T cell cytokine levels could serve as biomarkers to distinguish AIN from other causes of acute kidney disease (AKD).METHODS We enrolled consecutive sampling participants who underwent a kidney biopsy for AKD evaluation at 2 centers between 2015 and 2018. Three pathologists independently established AIN diagnosis through review of kidney biopsies. Through univariable and multivariable analysis of 12 selected urine and plasma cytokines, we identified 2 that were diagnostic of AIN.RESULTS Of the 218 participants, 32 (15%) were diagnosed with AIN by all 3 pathologists. Participants with AIN had consistently higher levels of urine TNF-α and IL-9 than those with other diagnoses, including acute tubular injury, glomerular diseases, and diabetic kidney disease, and those without any kidney disease. As compared with participants in the lowest quartile, we noted higher odds of AIN in participants in the highest quartiles of TNF-α levels (adjusted odds ratio, 10.9 [1.8, 65.9]) and IL-9 levels (7.5 [1.2, 45.7]) when controlling for blood eosinophils, leukocyturia, and proteinuria. Addition of biomarkers improved area under receiver operating characteristic curve over clinicians’ prebiopsy diagnosis (0.84 [0.78, 0.91]) vs. 0.62 [(0.53, 0.71]) and a model of current tests (0.84 [0.76, 0.91] vs. 0.69 [0.58, 0.80]).CONCLUSIONS Inclusion of urinary TNF-α and IL-9 improves discrimination over clinicians’ prebiopsy diagnosis and currently available tests for AIN diagnosis.FUNDING Supported by NIH awards K23DK117065, T32DK007276, K24DK090203, K23DK097201, R01DK113191, UG3-DK114866, P30DK079310; the Robert E. Leet and Clara Guthrie Patterson Trust; and American Heart Association award 18CDA34060118.

Authors

Dennis G. Moledina, F. Perry Wilson, Jordan S. Pober, Mark A. Perazella, Nikhil Singh, Randy L. Luciano, Wassim Obeid, Haiqun Lin, Michael Kuperman, Gilbert W. Moeckel, Michael Kashgarian, Lloyd G. Cantley, Chirag R. Parikh

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 8 16 14 17 17 8 4 84
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2021 (17)

Title and authors Publication Year
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
JS Lin, O Mamlouk, U Selamet, A Tchakarov, WF Glass, RA Sheth, RM Layman, R Dadu, N Abdel-Wahab, M Abdelrahim, A Diab, C Yee, A Abudayyeh
OncoImmunology 2021
Close Association Between Altered Urine-urothelium Barrier and Tertiary Lymphoid Structure Formation in the Renal Pelvis During Nephritis
O Ichii, M Hosotani, A Masum, T Horino, T Nakamura, T Namba, Y Otani, Y Elewa, Y Kon
Journal of the American Society of Nephrology : JASN 2021
Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
, Z Li, R Lin, J Shan, Q Yu, R Wang, L Liao, W Yan, Z Wang, L Shang, Y Huang, Q Zhang, K Xiong
Frontiers in Cell and Developmental Biology 2021
Tubulointerstitial nephritis and uveitis syndrome following meningitis and systemic lymphadenopathy with persistent Toxoplasma immunoglobulin M: a case report
Y Oya, H Futami, T Nakazawa, K Ishijima, K Umemiya, F Takizawa, N Imai, H Kitamura, R Matsumura
Journal of medical case reports 2021
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese
X Zhou, LC Tsoi, Y Hu, MT Patrick, K He, CC Berthier, Y Li, Y Wang, Y Qi, Y Zhang, T Gan, Y Li, P Hou, L Liu, S Shi, J Lv, H Xu, H Zhang
Clinical journal of the American Society of Nephrology : CJASN 2021
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
S Menez, DG Moledina, H Thiessen-Philbrook, FP Wilson, W Obeid, M Simonov, Y Yamamoto, CP Corona-Villalobos, C Chang, BT Garibaldi, W Clarke, S Farhadian, CD Cruz, SG Coca, CR Parikh
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study
DG Moledina, M Simonov, Y Yamamoto, J Alausa, T Arora, A Biswas, LG Cantley, L Ghazi, JH Greenberg, M Hinchcliff, C Huang, SG Mansour, M Martin, A Peixoto, W Schulz, L Subair, JM Testani, U Ugwuowo, P Young, FP Wilson
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events
B Adam, N Murakami, G Reid, K Du, R Jasim, C Boils, L Bu, P Hill, A Murray, K Renaudin, C Roufosse, A Weins, K Wen, L Riella, M Mengel
Clinical journal of the American Society of Nephrology : CJASN 2021
Ibrutinib-induced acute kidney injury via interstitial nephritis.
Markóth C, File I, Szász R, Bidiga L, Balla J, Mátyus J
Renal Failure 2021
The Challenges of Acute Interstitial Nephritis: Time to Standardize.
Moledina DG, Perazella MA
2021
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations.
Perazella MA, Sprangers B
Clinical Kidney Journal 2021
The Promise of Tubule Biomarkers in Kidney Disease: A Review.
Ix JH, Shlipak MG
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment.
Martinez Valenzuela L, Draibe J, Bestard O, Fulladosa X, Gómez-Preciado F, Antón P, Nadal E, Jové M, Cruzado JM, Torras J
Journal of Clinical Medicine 2021
Potential Value of TNF-α (-376 G/A) Polymorphism and Cystatin C (CysC) in the Diagnosis of Sepsis Associated Acute Kidney Injury (S-AK I) and Prediction of Mortality in Critically Ill patients.
Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HFM
Frontiers in Molecular Biosciences 2021
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.
Seethapathy H, Herrmann SM, Sise ME
2021
Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis.
Moledina DG, Wilson FP, Kukova L, Obeid W, Luciano R, Kuperman M, Moeckel GW, Kashgarian M, Perazella MA, Cantley LG, Parikh CR
Nephrology Dialysis Transplantation 2021
Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: PRO
Cavanaugh C
2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts